Comac Medical presents newly available data of successfully completed clinical trials at AASLD The Liver Meeting

We are happy to share that Comac Medical has been assigned with conducting Phase 2 randomized, placebo-controlled GULLIVER-2 trial. The results of the study were presented at AASLD The Liver Meeting on 4^th-8^th November.
Check the results in the following document.